When Jeff Sessions personally asked Congress to repeal states’ protections regarding medical marijuana, advocates across the country became incensed-and for good reason. It seems that the Attorney General is keen on fueling the dying war on drugs, and doesn’t mind acting against the will of the American people-who overwhelmingly support legalization of medicinal marijuana. His ambition hasn’t yielded much support, and actually seems to have lit a fire under those who were unsure of their position before, or who hadn’t acted upon it.
Now state Senators Rand Paul (R-Kentucky), Corey Booker (D-New Jersey) and Kirsten Gillibrand (D-New York) are calling on the federal government to rescind the federal-level prohibition of medical marijuana.
The Compassionate Access, Research Expansion and Respect States Act (or CARERS Act, for short) aims to change the Controlled Substances Act by preventing the government from prosecuting individuals and marijuana-related businesses in states that have a medical marijuana program.
One substantial issue addressed by the CARERS Act is the greatly limiting restrictions imposed by the federal government that interfere and even prevent comprehensive research into marijuana’s medical benefits. “The federal government should not be meddling in state laws that allow it or obstructing research into its many medical benefits,” declared Don Murphy of the Marijuana Policy Project.
Twenty-nine states and the District of Colombia have legalized medical marijuana for sufferers of a host of ailments ranging from anxiety to cancer, and researchers suspect that it’s just the tip of the ice berg. Limited studies have been conducted on marijuana’s effectiveness to treat major drug-resistant seizure disorders as well as combat the debilitating effects of Alzheimer’s and age-related dementia.
More comprehensive research into the medicinal qualities of the plant and its THC and CBD components would only stand to benefit Americans by increasing their access to quality medicine. Unfortunately, this progress is greatly hindered by federal restrictions that make it difficult for researchers to obtain the permits required to conduct their studies.
When it comes to medicine, there is no such thing as knowing “too much.” However, it is detrimental and downright damaging to operate with too little knowledge. Think of all of the people whom medicinal marijuana could be helping-if only the science to back it up existed.